{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:33:51Z","timestamp":1772580831423,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3568,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1038\/sj.ki.5000253","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T16:14:49Z","timestamp":1140020089000},"page":"963-966","source":"Crossref","is-referenced-by-count":67,"title":["Vascular tone control in humans: Insights from studies in Bartter's\/Gitelman's syndromes"],"prefix":"10.1016","volume":"69","author":[{"given":"L.A.","family":"Cal\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5000253_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11906-003-0073-2","article-title":"Role of angiotensin II in regulating vascular structural and functional changes in hypertension","volume":"5","author":"Touyz","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/sj.ki.5000253_bb0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.37.4.1047","article-title":"Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis","volume":"37","author":"Dzau","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5000253_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/361315a0","article-title":"Inositol trisphosphate and calcium signalling","volume":"361","author":"Berridge","year":"1993","journal-title":"Nature"},{"key":"10.1038\/sj.ki.5000253_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1152\/physrev.1999.79.2.387","article-title":"Signaling mechanisms underlying the vascular myogenic response","volume":"70","author":"Davis Mj","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1038\/sj.ki.5000253_bb0030","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine\u2013nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000253_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0006-2952(97)00375-4","article-title":"Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis","volume":"55","author":"Clementi","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/sj.ki.5000253_bb0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10408360091174295","article-title":"Regulation of vascular tone in Bartter's and Gitelman's syndromes","volume":"37","author":"Cal\u00f2","year":"2000","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1038\/sj.ki.5000253_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00151642-200512010-00004","article-title":"Angiotensin ii signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension","volume":"12","author":"Cal\u00f2","year":"2005","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1038\/sj.ki.5000253_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000076752","article-title":"Bartter's and Gitelman's syndromes: from gene to clinic","volume":"96","author":"Naesens","year":"2004","journal-title":"Nephron Physiol"},{"key":"10.1038\/sj.ki.5000253_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP59393","article-title":"Bartter's\/Gitelman's syndrome: a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling","volume":"59","author":"Cal\u00f2","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5000253_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1050-1738(97)00143-6","article-title":"Specificity of Gq and G11 protein signaling in vascular myocites","volume":"8","author":"Mironneau","year":"1998","journal-title":"Trends Cardiovasc Med"},{"key":"10.1038\/sj.ki.5000253_bb0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0006-291X(83)91217-2","article-title":"Angiotensin II receptors negatively coupled to adenylate cyclase in rat aorta","volume":"117","author":"Anand-Srivastava","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/sj.ki.5000253_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-003-0013-1","article-title":"The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction","volume":"5","author":"Sward","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/sj.ki.5000253_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-2952(89)90389-4","article-title":"Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein","volume":"38","author":"Anand-Srivastava","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/sj.ki.5000253_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","article-title":"Rho\u2013Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells","volume":"22","author":"Fukata","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1038\/sj.ki.5000253_bb0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1523-1755.2001.060003882.x","article-title":"Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes","volume":"60","author":"Cal\u00f2","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000253_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2002.00128.x","article-title":"Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity","volume":"61","author":"Cal\u00f2","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000253_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/cs0720483","article-title":"Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome","volume":"72","author":"Di Virgilio","year":"1987","journal-title":"Clin Sci"},{"key":"10.1038\/sj.ki.5000253_bb0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000188941","article-title":"Intracellular calcium signalling and vascular reactivity in Bartter's syndrome","volume":"72","author":"Calo","year":"1996","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5000253_bb0105","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/00004872-200410000-00019","article-title":"Rho kinase and PAI-1 in Bartter's\/Gitelman's syndromes: relationship to angiotensin II signaling","volume":"22","author":"Pagnin","year":"2004","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0110","first-page":"12","article-title":"Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity","volume":"51","author":"Cal\u00f2","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5000253_bb0115","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0272-6386(96)90514-4","article-title":"Increased urinary NO2\u2212\/NO3\u2212 and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity","volume":"27","author":"Cal\u00f2","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000253_bb0120","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","article-title":"Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3 kinase\/protein kinase Akt and cardiovascular protection","volume":"24","author":"Wolfrum","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/sj.ki.5000253_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004872-200501000-00017","article-title":"Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress\u2013LOX-1 pathway in Dahl salt-sensitive hypertensive rats","volume":"23","author":"Mita","year":"2005","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0130","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfg204","article-title":"Oxidative stress related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling","volume":"18","author":"Cal\u00f2","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000253_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pharmtox.37.1.517","article-title":"The heme oxygenase system: a regulator of second messenger gases","volume":"37","author":"Maines","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1038\/sj.ki.5000253_bb0140","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1074\/jbc.M309660200","article-title":"Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase\/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol","volume":"279","author":"Martin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000253_bb0145","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G-proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1038\/sj.ki.5000253_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.pharmtox.40.1.459","article-title":"The role of Rho in G protein-coupled receptor signal transduction","volume":"40","author":"Sah","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1038\/sj.ki.5000253_bb0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.biochem.69.1.795","article-title":"GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins","volume":"69","author":"Ross","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/sj.ki.5000253_bb0160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.amjhyper.2004.05.006","article-title":"Increased expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats","volume":"17","author":"Ying","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0165-6147(99)01369-3","article-title":"Emerging roles for RGS proteins in cell signalling","volume":"20","author":"Hepler","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1038\/sj.ki.5000253_bb0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0022-3565(24)29606-3","article-title":"Regulator of G protein signalling proteins; novel multifunctional drug targets","volume":"297","author":"Zhong","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/sj.ki.5000253_bb0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1172\/JCI15598","article-title":"Hypertension and prolonged vasoconstrictor signalling in RGS2-deficient mice","volume":"111","author":"Heximer","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000253_bb0180","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/nm958","article-title":"Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure","volume":"9","author":"Tang","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/sj.ki.5000253_bb0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cardiores.2005.02.005","article-title":"Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells","volume":"66","author":"Li","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1038\/sj.ki.5000253_bb0190","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1210\/jc.2004-0498","article-title":"Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's\/Gitelman's sydrome. A role in the control of vascular tone and implication for hypertension","volume":"89","author":"Cal\u00f2","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5000253_bb0195","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1097\/00004872-200406002-00502","article-title":"RGS2 expression and intracellular calcium mobilization in fibroblasts from hypertensive patients","volume":"22","author":"Sartori","year":"2004","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0200","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00004872-200404000-00022","article-title":"Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals","volume":"22","author":"Baritono","year":"2004","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(80)90351-4","article-title":"A defect in platelet aggregation in Bartter's syndrome","volume":"68","author":"Stoff","year":"1980","journal-title":"Am J Med"},{"key":"10.1038\/sj.ki.5000253_bb0210","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjhyper.2005.03.747","article-title":"Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes. Relevance for the pathophysiology of hypertension","volume":"18","author":"Pagnin","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0215","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/01.CIR.0000093661.90582.c4","article-title":"Oxidative stress and cardiovascular injury: part II: animal and human studies","volume":"108","author":"Griendling","year":"2003","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000253_bb0220","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase. Role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"10.1038\/sj.ki.5000253_bb0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1523-1755.1998.00778.x","article-title":"Redox regulation of renal DNA synthesis, transforming growth factor-beta-1 and collagen gene expression","volume":"53","author":"Nath","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000253_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1050-1738(97)00133-3","article-title":"Reactive oxygen species as mediators of signal transduction in cardiovascular disease","volume":"8","author":"Abe","year":"1998","journal-title":"Trends Cardiovasc Med"},{"key":"10.1038\/sj.ki.5000253_bb0235","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0006-2952(00)00443-3","article-title":"Gene regulation of heme oxygenase-1 as a therapeutic target","volume":"60","author":"Immenschuh","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/sj.ki.5000253_bb0240","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00004872-199816070-00014","article-title":"Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome)","volume":"16","author":"Cal\u00f2","year":"1998","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0245","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/01.hjh.0000170394.99697.b3","article-title":"Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection","volume":"23","author":"Cal\u00f2","year":"2005","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000253_bb0250","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/01.ATV.0000153089.74997.02","article-title":"Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome","volume":"25","author":"Calo","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815516153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815516153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T19:40:56Z","timestamp":1736278856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815516153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0085253815516153"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5000253","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}